Number | Cited Articles |
1 |
Rui Wang, Sean Graham, Ning Sun, Donna McCarthy, Ruoqi Peng, Jamie Erickson, Liz Oconnor, Xiaochun Zhu, Marc Wurbel, Robert Dunstan, Susan Westmoreland, Namjin Chung, Tariq Ghayur, Jijie Gu, Edda Fiebiger. CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40. PLOS ONE 2020; 15(3): e0228221 doi: 10.1371/journal.pone.0228221
|
2 |
Miao Wu, Niandan Hu, Xianjin Du, Jie Wei. Application of CRISPR/Cas9 technology in sepsis research. Briefings in Functional Genomics 2020; 19(3): 229 doi: 10.1093/bfgp/elz040
|